203 related articles for article (PubMed ID: 15816878)
1. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.
Hesselink DA; van Hest RM; Mathot RA; Bonthuis F; Weimar W; de Bruin RW; van Gelder T
Am J Transplant; 2005 May; 5(5):987-94. PubMed ID: 15816878
[TBL] [Abstract][Full Text] [Related]
2. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.
El-Sheikh AA; Koenderink JB; Wouterse AC; van den Broek PH; Verweij VG; Masereeuw R; Russel FG
Transl Res; 2014 Jul; 164(1):46-56. PubMed ID: 24486136
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats.
Kobayashi M; Saitoh H; Kobayashi M; Tadano K; Takahashi Y; Hirano T
J Pharmacol Exp Ther; 2004 Jun; 309(3):1029-35. PubMed ID: 14978191
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.
Brown NW; Aw MM; Mieli-Vergani G; Dhawan A; Tredger JM
Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
8. The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice.
Wang J; Figurski M; Shaw LM; Burckart GJ
Transpl Immunol; 2008 Jul; 19(3-4):192-6. PubMed ID: 18586494
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.
Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S
Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031
[TBL] [Abstract][Full Text] [Related]
11. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
[TBL] [Abstract][Full Text] [Related]
12. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
[TBL] [Abstract][Full Text] [Related]
13. Influence of metal cations on plasma trough concentration of mycophenolic Acid and its glucuronide in tacrolimus-treated and cyclosporine-treated kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
Biol Pharm Bull; 2008 Jun; 31(6):1292-6. PubMed ID: 18520072
[TBL] [Abstract][Full Text] [Related]
14. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
15. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients.
Heller T; van Gelder T; Budde K; de Fijter JW; Kuypers D; Arns W; Schmidt J; Rostaing L; Powis SH; Claesson K; Macphee IA; Pohanka E; Engelmayer J; Brandhorst G; Oellerich M; Armstrong VW
Am J Transplant; 2007 Jul; 7(7):1822-31. PubMed ID: 17532750
[TBL] [Abstract][Full Text] [Related]
17. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
Morissette P; Albert C; Busque S; St-Louis G; Vinet B
Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
19. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
Naito T; Mino Y; Otsuka A; Ushiyama T; Ito T; Ozono S; Kagawa Y; Kawakami J
J Clin Pharmacol; 2009 Jun; 49(6):710-8. PubMed ID: 19451405
[TBL] [Abstract][Full Text] [Related]
20. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
